Find Information About:

Drugs & Supplements

Get information and reviews on prescription drugs, over-the-counter medications, vitamins, and supplements. Search by name or medical condition.

Pill Identifier

Pill Identifier

Having trouble identifying your pills?

Enter the shape, color, or imprint of your prescription or OTC drug. Our pill identification tool will display pictures that you can compare to your pill.

Get Started

My Medicine

Save your medicine, check interactions, sign up for FDA alerts, create family profiles and more.

Get Started

WebMD Health Experts and Community

Talk to health experts and other people like you in WebMD's Communities. It's a safe forum where you can create or participate in support groups and discussions about health topics that interest you.

  • Second Opinion

    Second Opinion

    Read expert perspectives on popular health topics.

  • Community


    Connect with people like you, and get expert guidance on living a healthy life.

Got a health question? Get answers provided by leading organizations, doctors, and experts.

Get Answers

Sign up to receive WebMD's award-winning content delivered to your inbox.

Sign Up

Osteoporosis Health Center

Font Size

FDA OKs Generic Boniva for Bone Loss

3 Firms to Sell Ibandronate, Once-Monthly Osteoporosis Pill
WebMD Health News
Reviewed by Laura J. Martin, MD

March 19, 2012 -- Three generic drugmakers may now sell their own versions of the bone-loss drug Boniva, the FDA ruled today.

Boniva, known by the generic name ibandronate, is a once-a-month pill prescribed to prevent or to treat bone loss from osteoporosis.

The FDA officially approves Boniva only for treatment of postmenopausal women, as the clinical studies that led to approval mostly enrolled women. However, doctors often prescribe the drug to men.

Overall, some 40 million Americans either suffer osteoporosis or are at high risk of the condition, which can lead to devastating bone fractures.

"Men as well as women are affected by osteoporosis, a disease that can be prevented and treated," Keith Webber, PhD, an FDA deputy director, says in a news release.

Boniva is a member of a class of drugs called bisphosphonates, which help build bone.

Webber said the newly approved generic versions of Boniva should make the medication more affordable.

Generic ibandronate will be made by three firms: Apotex Inc., Orchid Healthcare, and Mylan Pharmaceuticals Inc. They will make 150 milligram ibandronate tablets.

The FDA will require each firm to give patients a medication guide describing the drug's risks. Ibandronate can cause serious side effects including esophagus problems; low calcium levels in the blood; bone, joint, or muscle pain; severe jawbone problems; and unusual thigh bone fractures.

In clinical trials for Boniva, the most commonly observed adverse reactions were back pain, indigestion, pain in the arms or legs, diarrhea, headache, and muscle pain.

Today on WebMD

Women working out and walking with weights
Reduce bone loss and build stronger muscles.
Chinese cabbage
Calcium-rich foods to add to your diet.
woman stretching
Get the facts on osteoporosis.
Porous bone
Causes, symptoms, risk factors, and treatment.
senior woman
Woman holding plate of brocolli
wrist xray
Superfood for Bones
mature woman
sunlight in hands
man and woman in front of xray
woman with dumbbells